Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 M<sup>pro</sup>

DOI オープンアクセス

説明

<p>Correction for ‘Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro’ by Vishal M. Balaramnavar <italic>et al.</italic>, <italic>RSC Adv.</italic>, 2020, 10, 40264–40275, DOI: 10.1039/D0RA06038K.</p>

収録刊行物

  • RSC Advances

    RSC Advances 10 42765-42765, 2020-01-01

    Royal Society of Chemistry (RSC)

詳細情報 詳細情報について

  • CRID
    1872553967752656256
  • DOI
    10.1039/d0ra90120b
  • ISSN
    20462069
  • データソース種別
    • OpenAIRE

問題の指摘

ページトップへ